Beate Krammer-Steiner
Overview
Explore the profile of Beate Krammer-Steiner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pfrepper C, Siecke A, Klamroth R, Kuhnol C, Kentouche K, Holzhauer S, et al.
Hamostaseologie
. 2025 Feb;
PMID: 39965757
Introduction: Treatment options for patients with hemophilia (PWH) have changed substantially in the last years. This study aimed to compare hemophilia treatment in the eastern part of Germany in 2021...
2.
Haack L, Dasenbrook B, Steiner P, Krammer-Steiner B, Steiner M, Stubert J
Fertil Steril
. 2024 Nov;
PMID: 39580045
No abstract available.
3.
Toenges R, Miesbach W, Ludwig K, Krammer-Steiner B
Blood Coagul Fibrinolysis
. 2024 Jan;
35(2):49-55.
PMID: 38179696
Objectives: Patients with von Willebrand disease (vWD) undergoing surgery are routinely treated with von Willebrand factor (vWF)/factor VIII (FVIII) concentrate to control bleeding risk, but consensus is lacking on optimal...
4.
Thurner L, Ziepert M, Berdel C, Schmidt C, Borchmann P, Kaddu-Mulindwa D, et al.
Hemasphere
. 2023 Jul;
7(7):e904.
PMID: 37427146
UNFOLDER (Unfavorable Young Low-Risk Densification of R-Chemo Regimens) is an international phase-3 trial in patients 18-60 years with aggressive B-cell lymphoma and intermediate prognosis defined by age-adjusted International Prognostic Index...
5.
Held G, Thurner L, Poeschel V, Ott G, Schmidt C, Christofyllakis K, et al.
Hemasphere
. 2023 Jul;
7(7):e917.
PMID: 37427145
UNFOLDER (NCT00278408, EUDRACT 2005-005218-19) is a phase-3 trial in patients with aggressive B-cell lymphoma and intermediate prognosis, including primary mediastinal B-cell lymphoma (PMBCL). In a 2 × 2 factorial design,...
6.
Stintzing S, Heinrich K, Tougeron D, Modest D, Schwaner I, Eucker J, et al.
J Clin Oncol
. 2023 Jun;
41(25):4143-4153.
PMID: 37352476
Purpose: mutation is associated with a poor outcome in metastatic colorectal cancer (mCRC). This clinical trial investigated the efficacy of triplet chemotherapy (fluorouracil, folinic acid, oxaliplatin, and irinotecan) combined with...
7.
Betge J, Schulte N, Belle S, Zhan T, Krammer-Steiner B, Moulin J, et al.
J Geriatr Oncol
. 2022 Jan;
13(5):662-666.
PMID: 34991998
Background: Older patients with metastatic pancreatic cancer may suffer increased toxicity from intensive chemotherapy. Treatment individualization by geriatric assessment (GA) might improve functional outcome. Methods: We performed a multicenter, phase...
8.
Brioli A, Manz K, Pfirrmann M, Hanel M, Schwarzer A, Prange-Krex G, et al.
J Cancer Res Clin Oncol
. 2019 Dec;
146(3):749-759.
PMID: 31788741
Purpose: The German Maintenance Study (GERMAIN) was designed to evaluate the impact of lenalidomide maintenance after induction therapy with bortezomib, melphalan and prednisolone (VMP) in transplant-ineligible newly diagnosed multiple myeloma...
9.
Mahn R, Schilling K, Klamroth R, Kentouche K, Aumann V, Fischer L, et al.
Hamostaseologie
. 2019 Nov;
40(1):119-127.
PMID: 31711245
Introduction: In 2005 the Kompetenznetz Hämorrhagische Diathese Ost published epidemiologic data about patients with haemophilia A (HA) and haemophilia B (HB) in the eastern part of Germany. This study provides...
10.
Hegewisch-Becker S, Aldaoud A, Wolf T, Krammer-Steiner B, Linde H, Scheiner-Sparna R, et al.
Int J Cancer
. 2018 Jul;
144(5):981-990.
PMID: 30006989
Pancreatic cancer is a highly lethal malignancy. Developments in recent years have broadened our therapeutic armamentarium. Novel drugs such as nab-paclitaxel, liposomal irinotecan and chemotherapy regimens such as FOLFIRINOX have...